Prescription and Over-the-Counter Drug Misuse

Among the Elderly
 by David W. Oslin, M.D.
Geriatric Times  May/June 2000  Vol. I  Issue 1



It is well-documented that older adult patients are the largest consumers of prescription medications. Recent estimates show that adults age 60 and older take an average of five prescription medications each day (Golden et al., 1999). In 1997, Stoehr and colleagues found that 87% of older individuals (mean age 74.5 years) reported regular use of at least one over-the-counter (OTC) medication, and 5.7% were taking five or more OTC medications daily. Given the recent rise in use of nutriceuticals such as herbal remedies, these figures are likely to be underestimates. There has been consistent concern that the number of medications taken by older adult patients can lead to an excess in disability and the potential for life-threatening illness. This concern was highlighted in a recent U.S. General Accounting Office report on adverse drug events (2000). Furthermore, it is important to consider specifically the effects of central nervous system active medications because they are commonly used by older adults and because the brain is the most vulnerable of human systems.

What lies behind the use of a large number of medications? Does this polypharmacy represent medication mismanagement, or is it merely reflective of the increased number of illnesses present later in life? Perhaps the quantity of medications is reflective of medical science's advances, which have produced medications with greater specificity and more combination treatment.

Despite the growing number of available medications, however, it is likely there is significant misuse, such as using medications with non demonstrated efficacy for the patient's symptoms or illness, using medications with excessive risks among the elderly and continuing medications without specified benefit.

Indeed, a 1999 study of older primary care patients by Straand and Rokstad estimated that 13.5% of all prescriptions given during a two-month period were inappropriate, based upon excessive dosing, potentially harmful drug combinations or the use of contraindicated medications for an older adult population.

Also well-documented are concerns about the use of multiple medications and the possible exposure to a greater number of adverse events, increased financial costs, drug interactions (leading to unique adverse effects or a change in an agent's efficacy), and increased errors in taking the medications on a proper schedule. Thus, the solution seems simple. Clinicians should be fastidious about the purpose of each medicine used (both prescription and OTC), as well as the withdrawal of medications with
no demonstrated effect. Moreover, they should avoid certain medication and drug combinations that are especially hazardous in older adults. This task is complicated because health care for the elderly tends to be fragmented among several providers, and each clinician has less time to see patients or to monitor all aspects of a patient's health care.

Each treatment we prescribe or recommend has certain risks and benefits. Properly weighed, this ratio should favor a benefit. Having said this, certain medications are associated with greater risk than others. For instance, benzodiazepines can increase the risk of falls and thus fractures (Gales and Menard, 1995; Herings et al., 1995), cause impairment to driving skills (Hemmelgarn et al., 1997), disrupt sleep cycles (Newman et al., 1997) and, among the frail elderly, cause excessive disability
(Ried et al., 1998).

Similarly, diphenhydramine (Benadryl) has been shown to produce cognitive deficits in healthy elderly patients, raising the possibility of excessive cognitive deficits in patients with dementing illnesses (Katz et al., 1998; Morrison and Katz, 1989).

Risk exposure is heightened when the medication is used for a longer duration than intended or warranted, or when the medication is improperly prescribed (e.g., giving an excessive dose or prescribing the medication for the wrong indication). Examples among the elderly include: prolonged use of sedative medications such as benzodiazepines or diphenhydramine for insomnia; use of anti-anxiety medications for the treatment of depression or chronic pain; and the use of high doses of antipsychotics for the treatment of behavioral disturbances associated with dementia.

One approach to reducing the number of inappropriate medications is to develop medication-specific policies that either limit access to use or trigger inquires about use. Conceptually, a threshold can be set for both dose and duration of exposure allowing detection of patients taking high doses of a medication and those on medications longer than would be reasonable clinical practice. In HMOs, this type of tracking easily could be implemented using prescription claims.

As another example, a multisite collaborative project, funded by the Substance Abuse and Mental Health Services Administration and the U.S. Department of Veterans Affairs, recommended targeting patterns of near daily use of benzodiazepines or opioids for more than three months. As part of this study, patients enrolled in primary care were asked about their medication use. Those who were above the threshold for use were referred for an evaluation of the prescription's medical necessity. Following passage of the Omnibus Budget Reconciliation Act of 1987, this approach was adopted in nursing home regulations that require justification of use of a variety of medications, including benzodiazepines and antipsychotics, that exceed certain dose limits.

Using treatment guidelines for various disorders is another approach to improved medication use. This methodology has been used in various disease management programs and in guideline-driven care for disorders such as depression, diabetes, hypertension and congestive heart failure. The purpose of providing guideline-adherent or algorithm-based care is to increase the precision of prescribing, document response and eliminate drugs that do not demonstrate the desired effect. (The American Psychiatric Association has 10 guidelines for psychiatric disorders posted on its Web site www.psych.org in the clinical resources section. Other guidelines are available at the National Guideline Clearinghouse www.guideline.gov-Ed.) Computer-assisted programs are being developed that trigger reminders to conduct assessmeents at specific points in the treatment. The assessments are fed back into the computer to determine response over time. The clinician then can be provided with treatment suggestions.

In summary, many older adults suffer from multiple medical problems, each warranting treatment. In many instances, this leads to an appropriate degree of polypharmacy. It is incumbent upon us as clinicians, however, to be ever careful about the rationale for using each medication and to have clear goals when starting new medications. These goals should always include target responses and contingencies for discontinuing medications that cause excessive adverse effects or do not demonstrate the desired response. The use of algorithms, computer-assisted programs and other tools should be embraced, not feared, by clinicians, as these will ultimately lead to better care for our patients.

Dr. Oslin is assistant professor in addiction and geriatric psychiatry in the department of geriatric psychiatry at the University of Pennsylvania


http://www.cmellc.com/geriatrictimes/g000629.html

- 3 -

Page: Claude Pepper Cover Page

2

3

4

5

6

7 8 9 10  3Prev Next 4